DK1725567T3 - Spirocykliske cyclohexanderivater med affinitet for ORL1-receptoren - Google Patents

Spirocykliske cyclohexanderivater med affinitet for ORL1-receptoren

Info

Publication number: DK1725567T3
Authority: DK; Denmark
Prior art keywords: affinity; cyclohexane derivatives; orl1 receptor; spirocyclic cyclohexane; spirocyclic
Prior art date: 2003-12-23

Application number

DK04804136T

Other languages

Danish (da)

English (en)

Inventor

Hans Schick

Claudia Hinze

Bernd Sundermann

Birgitta Henkel

Werner Englberger

Stefan Oberboersch

Elmar Friderichs

Sven Frormann

Babette-Yvonne Koegel

Klaus Linz

Beatrix Merla

Derek Saunders

Wolfgang Schroeder

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-23

Filing date

2004-12-21

Publication date

2008-06-16

2004-12-21 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2008-06-16 Application granted granted Critical

2008-06-16 Publication of DK1725567T3 publication Critical patent/DK1725567T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Psychiatry (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Anesthesiology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK04804136T 2003-12-23 2004-12-21 Spirocykliske cyclohexanderivater med affinitet for ORL1-receptoren DK1725567T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10360792A DE10360792A1 (de)	2003-12-23	2003-12-23	Spirocyclische Cyclohexan-Derivate
PCT/EP2004/014539 WO2005066183A1 (de)	2003-12-23	2004-12-21	Spirocyclische cyclohexan-derivate mit affinität zum orl1-rezeptor

Publications (1)

Publication Number	Publication Date
DK1725567T3 true DK1725567T3 (da)	2008-06-16

Family

ID=34706497

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04804136T DK1725567T3 (da)	2003-12-23	2004-12-21	Spirocykliske cyclohexanderivater med affinitet for ORL1-receptoren

Country Status (27)

Country	Link
US (1)	US7332519B2 (es)
EP (1)	EP1725567B1 (es)
JP (1)	JP4885733B2 (es)
KR (1)	KR101152693B1 (es)
CN (1)	CN1922189B (es)
AR (1)	AR047163A1 (es)
AT (1)	ATE390430T1 (es)
AU (1)	AU2004312147B2 (es)
BR (1)	BRPI0418052A2 (es)
CA (1)	CA2550868C (es)
CY (1)	CY1107975T1 (es)
DE (2)	DE10360792A1 (es)
DK (1)	DK1725567T3 (es)
EC (1)	ECSP066667A (es)
ES (1)	ES2303964T3 (es)
HR (1)	HRP20080272T3 (es)
IL (1)	IL176457A (es)
MX (1)	MXPA06007171A (es)
NO (1)	NO337127B1 (es)
NZ (1)	NZ548317A (es)
PE (1)	PE20050758A1 (es)
PL (1)	PL1725567T3 (es)
PT (1)	PT1725567E (es)
RU (1)	RU2383544C2 (es)
SI (1)	SI1725567T1 (es)
WO (1)	WO2005066183A1 (es)
ZA (1)	ZA200606067B (es)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7776314B2 (en)	2002-06-17	2010-08-17	Grunenthal Gmbh	Abuse-proofed dosage system
DE10252667A1 (de)	2002-11-11	2004-05-27	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
US8075872B2 (en)	2003-08-06	2011-12-13	Gruenenthal Gmbh	Abuse-proofed dosage form
DE10336400A1 (de)	2003-08-06	2005-03-24	Grünenthal GmbH	Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de)	2003-12-24	2005-09-29	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en)	2003-08-06	2007-03-01	Elisabeth Arkenau-Maric	Abuse-proofed dosage form
DE102004032051A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE102005005446A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10360793A1 (de) *	2003-12-23	2005-07-28	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE102004032049A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005016460A1 (de) *	2005-04-11	2006-10-19	Grünenthal GmbH	Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
DE102006019597A1 (de)	2006-04-27	2007-10-31	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE102006033114A1 (de)	2006-07-18	2008-01-24	Grünenthal GmbH	Spirocyclische Azaindol-Derivate
EP1894938A1 (en) *	2006-08-31	2008-03-05	Evonik Degussa GmbH	New cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions
DE102006046745A1 (de) *	2006-09-29	2008-04-03	Grünenthal GmbH	Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
DE102007009319A1 (de)	2007-02-22	2008-08-28	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE102007009235A1 (de)	2007-02-22	2008-09-18	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE102007011485A1 (de)	2007-03-07	2008-09-11	Grünenthal GmbH	Darreichungsform mit erschwertem Missbrauch
EP2240481A1 (en)	2008-01-11	2010-10-20	Albany Molecular Research, Inc.	(1-azinone) -substituted pyridoindoles as mch antagonists
US8383152B2 (en)	2008-01-25	2013-02-26	Gruenenthal Gmbh	Pharmaceutical dosage form
SI2271613T1 (sl)	2008-03-27	2014-08-29	Grunenthal Gmbh	Hidroksimetilcikloheksilamini
US8288430B2 (en) *	2008-03-27	2012-10-16	Grunenthal Gmbh	Spiro(5.5)undecane derivatives
TWI450899B (zh) *	2008-03-27	2014-09-01		被取代之螺環環已烷衍生物
CA2719743A1 (en)	2008-03-27	2009-10-01	Gruenenthal Gmbh	Substituted cyclohexyldiamines
AR071066A1 (es)	2008-03-27	2010-05-26	Gruenenthal Chemie	Derivados de (hetero) aril-ciclohexano
RU2532545C2 (ru)	2008-03-27	2014-11-10	Грюненталь Гмбх	Замещенные производные 4-аминоциклогексана
TWI524904B (zh)	2008-05-09	2016-03-11	歌林達股份有限公司	製備醫藥用固體劑型，尤指錠劑之方法，及製備固體劑型，尤指錠劑之前驅物之方法
EP2356123B1 (en)	2008-11-13	2012-10-03	F.Hoffmann-La Roche Ag	Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
WO2011003005A1 (en) *	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
WO2011003012A1 (en) *	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
WO2011003021A1 (en) *	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
US8629158B2 (en) *	2009-07-01	2014-01-14	Albany Molecular Research, Inc.	Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
JP5667183B2 (ja)	2009-07-22	2015-02-12	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	加熱溶融押出成型した制御放出性投与剤型
NZ596668A (en)	2009-07-22	2013-09-27	Gruenenthal Chemie	Oxidation-stabilized tamper-resistant dosage form
MX2012005690A (es) *	2009-11-16	2012-06-13	Lilly Co Eli	Compuestos de espiropiperidina como antagonista del receptor orl-1.
UA107943C2 (xx) *	2009-11-16	2015-03-10	Lilly Co Eli	Сполуки спіропіперидину як антагоністи рецептора orl-1
UA109140C2 (uk)	2010-06-24	2015-07-27		Гетероциклічні сполуки бензодіоксолу або бензодіоксепіну як інгібітори фосфодіестераз
TWI582092B (zh)	2010-07-28	2017-05-11	歌林達股份有限公司	順式－四氫－螺旋（環己烷－１,１’－吡啶［３,４－b］吲哚）－４－胺－衍生物
ES2486791T3 (es)	2010-09-02	2014-08-19	Grünenthal GmbH	Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
RU2013114411A (ru)	2010-09-02	2014-10-10	Грюненталь Гмбх	Устойчивая к разрушению лекарственная форма, которая содержит анионный полимер
MX2013002293A (es)	2010-09-02	2013-05-09	Gruenenthal Gmbh	Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
WO2012088038A2 (en)	2010-12-21	2012-06-28	Albany Molecular Research, Inc.	Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
WO2012088124A2 (en)	2010-12-21	2012-06-28	Albany Molecular Research, Inc.	Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
PE20141650A1 (es)	2011-07-29	2014-11-22	Gruenenthal Chemie	Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco
EA201400172A1 (ru)	2011-07-29	2014-06-30	Грюненталь Гмбх	Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
LT2809320T (lt) *	2012-02-03	2017-05-25	Grünenthal GmbH	(1r,4r)-6`-fluor-(n-metil- arba n,n-dimetil-)-4-fenil-4`,9`-dihidro-3`h-spiro-[cikloheksan-1,1`-pirano[3,4,b]indol]-4-aminas fibromialgijos ir lėtinio nuovargio sindromo gydymui
WO2013127831A1 (en)	2012-02-28	2013-09-06	Grünenthal GmbH	Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
US20130225625A1 (en)	2012-02-28	2013-08-29	Grunenthal Gmbh	Tamper-resistant pharmaceutical dosage form comprising nonionic surfactant
ES2692944T3 (es)	2012-04-18	2018-12-05	Grünenthal GmbH	Forma de dosificación farmacéutica resistente a la manipulación y resistente a la descarga rápida de la dosis
US10064945B2 (en)	2012-05-11	2018-09-04	Gruenenthal Gmbh	Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
LT2846835T (lt)	2012-05-11	2017-12-27	Grünenthal GmbH	Termiškai suformuota, sugadinimui atspari vaistinė dozavimo forma, turinti cinko
US20130310435A1 (en) *	2012-05-18	2013-11-21	Gruenenthal Gmbh	Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US9320729B2 (en) *	2012-05-18	2016-04-26	Gruenenthal Gmbh	Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US9345689B2 (en) *	2012-05-18	2016-05-24	Gruenenthal Gmbh	Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant
US8912226B2 (en) *	2012-05-18	2014-12-16	Gruenenthal Gmbh	Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR
US9320725B2 (en)	2012-05-18	2016-04-26	Gruenenthal Gmbh	Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
US20130310385A1 (en)	2012-05-18	2013-11-21	Gruenenthal Gmbh	Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US9308196B2 (en) *	2012-05-18	2016-04-12	Gruenenthal Gmbh	Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
US9855286B2 (en) *	2012-05-18	2018-01-02	Gruenenthal Gmbh	Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
ES2658193T3 (es)	2013-03-15	2018-03-08	Grünenthal GmbH	Cis-(E)-4-(3-fluorofenil)-2',3',4',9'-tetrahidro-N,N-dimetil-2'-(1-oxo-3-fenil-2-propenil)-espiro[ciclohexano-1,1'[1H]-pirido[3,4-b]indol]-4-amina cristalina
BR112015026549A2 (pt)	2013-05-29	2017-07-25	Gruenenthal Gmbh	forma de dosagem à prova de violação contendo uma ou mais partículas
US9737490B2 (en)	2013-05-29	2017-08-22	Grünenthal GmbH	Tamper resistant dosage form with bimodal release profile
AU2014289187B2 (en)	2013-07-12	2019-07-11	Grunenthal Gmbh	Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
AU2014356581C1 (en)	2013-11-26	2020-05-28	Grunenthal Gmbh	Preparation of a powdery pharmaceutical composition by means of cryo-milling
WO2015091352A1 (en)	2013-12-16	2015-06-25	Grünenthal GmbH	Tamper resistant dosage form with bimodal release profile manufactured by co-extrusion
MX2016014738A (es)	2014-05-12	2017-03-06	Gruenenthal Gmbh	Formulacion en capsula de liberacion inmediata resistente a alteraciones que comprende tapentadol.
CN106456550A (zh)	2014-05-26	2017-02-22	格吕伦塔尔有限公司	避免乙醇剂量倾泻的多颗粒
TW201607923A (zh)	2014-07-15	2016-03-01	歌林達有限公司	被取代之氮螺環（４．５）癸烷衍生物
PL3169666T3 (pl)	2014-07-15	2019-03-29	Grünenthal GmbH	Podstawione pochodne azaspiro(4,5)dekanu
JP2018503693A (ja)	2015-02-03	2018-02-08	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	ポリエチレングリコールグラフトコポリマーを含む改変防止剤形
BR112017021475A2 (pt)	2015-04-24	2018-07-10	Gruenenthal Gmbh	forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
CA2998259A1 (en)	2015-09-10	2017-03-16	Grunenthal Gmbh	Protecting oral overdose with abuse deterrent immediate release formulations
KR20180108567A (ko)	2015-10-22	2018-10-04	주노 테라퓨틱스 게엠베하	형질도입을 위한 방법, 키트, 제제 및 장치
AU2017294524A1 (en)	2016-07-06	2018-12-20	Grünenthal GmbH	Reinforced pharmaceutical dosage form
GB202306662D0 (en)	2023-05-05	2023-06-21	Union Therapeutics As	Dosage regimen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3843681A (en) *	1971-06-01	1974-10-22	American Home Prod	1-carboxamido pyrano(thiopyrano)(3,4-6)indole derivatives
FR2663935A1 (fr) *	1990-06-27	1992-01-03	Adir	Nouveaux 1,2,3,4,5,6-hexahydroazepino [4,5-b] indoles et 1,2,3,4-tetrahydrobethacarbolines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
CN1169808C (zh) *	1998-06-12	2004-10-06	研究及应用科学协会股份有限公司	β-咔啉化合物
WO2000038720A1 (en) *	1998-12-24	2000-07-06	Meiji Seika Kaisha, Ltd.	Remedies for pain
DE10044649A1 (de) *	2000-09-08	2002-07-04	Gruenenthal Gmbh	Substituierte 4-Phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
DE10123163A1 (de) *	2001-05-09	2003-01-16	Gruenenthal Gmbh	Substituierte Cyclohexan-1,4-diaminderivate
DE10252667A1 (de) *	2002-11-11	2004-05-27	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE10360793A1 (de) *	2003-12-23	2005-07-28	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate

2003
- 2003-12-23 DE DE10360792A patent/DE10360792A1/de not_active Withdrawn
2004
- 2004-12-21 AU AU2004312147A patent/AU2004312147B2/en not_active Ceased
- 2004-12-21 NZ NZ548317A patent/NZ548317A/en not_active IP Right Cessation
- 2004-12-21 SI SI200430663T patent/SI1725567T1/sl unknown
- 2004-12-21 MX MXPA06007171A patent/MXPA06007171A/es active IP Right Grant
- 2004-12-21 EP EP04804136A patent/EP1725567B1/de not_active Expired - Lifetime
- 2004-12-21 BR BRPI0418052A patent/BRPI0418052A2/pt not_active Application Discontinuation
- 2004-12-21 PT PT04804136T patent/PT1725567E/pt unknown
- 2004-12-21 DE DE502004006697T patent/DE502004006697D1/de not_active Expired - Lifetime
- 2004-12-21 JP JP2006546040A patent/JP4885733B2/ja not_active Expired - Fee Related
- 2004-12-21 KR KR1020067014815A patent/KR101152693B1/ko not_active Expired - Fee Related
- 2004-12-21 AT AT04804136T patent/ATE390430T1/de active
- 2004-12-21 ES ES04804136T patent/ES2303964T3/es not_active Expired - Lifetime
- 2004-12-21 DK DK04804136T patent/DK1725567T3/da active
- 2004-12-21 RU RU2006126787/04A patent/RU2383544C2/ru not_active IP Right Cessation
- 2004-12-21 CA CA2550868A patent/CA2550868C/en not_active Expired - Fee Related
- 2004-12-21 CN CN2004800420360A patent/CN1922189B/zh not_active Expired - Fee Related
- 2004-12-21 PL PL04804136T patent/PL1725567T3/pl unknown
- 2004-12-21 HR HR20080272T patent/HRP20080272T3/xx unknown
- 2004-12-21 WO PCT/EP2004/014539 patent/WO2005066183A1/de not_active Ceased
- 2004-12-22 AR ARP040104857A patent/AR047163A1/es not_active Application Discontinuation
- 2004-12-23 US US11/019,372 patent/US7332519B2/en not_active Expired - Fee Related
2005
- 2005-01-03 PE PE2005000023A patent/PE20050758A1/es not_active Application Discontinuation
2006
- 2006-06-21 IL IL176457A patent/IL176457A/en not_active IP Right Cessation
- 2006-06-21 EC EC2006006667A patent/ECSP066667A/es unknown
- 2006-07-21 ZA ZA200606067A patent/ZA200606067B/en unknown
- 2006-07-24 NO NO20063422A patent/NO337127B1/no not_active IP Right Cessation
2008
- 2008-05-29 CY CY20081100557T patent/CY1107975T1/el unknown

Also Published As

Publication number	Publication date
JP4885733B2 (ja)	2012-02-29
CA2550868C (en)	2012-03-06
NO20063422L (no)	2006-09-25
AU2004312147A1 (en)	2005-07-21
SI1725567T1 (sl)	2008-06-30
NO337127B1 (no)	2016-01-25
ATE390430T1 (de)	2008-04-15
ZA200606067B (en)	2007-10-31
CA2550868A1 (en)	2005-07-21
ECSP066667A (es)	2006-10-25
ES2303964T3 (es)	2008-09-01
HK1095831A1 (zh)	2007-05-18
KR20070014117A (ko)	2007-01-31
RU2006126787A (ru)	2008-01-27
PT1725567E (pt)	2008-05-09
US7332519B2 (en)	2008-02-19
KR101152693B1 (ko)	2012-06-15
JP2007515446A (ja)	2007-06-14
BRPI0418052A2 (pt)	2017-04-18
AU2004312147B2 (en)	2010-06-10
PL1725567T3 (pl)	2008-09-30
EP1725567A1 (de)	2006-11-29
PE20050758A1 (es)	2005-10-18
AR047163A1 (es)	2006-01-11
CY1107975T1 (el)	2013-09-04
IL176457A0 (en)	2006-10-05
RU2383544C2 (ru)	2010-03-10
US20050192333A1 (en)	2005-09-01
CN1922189A (zh)	2007-02-28
CN1922189B (zh)	2010-06-16
EP1725567B1 (de)	2008-03-26
IL176457A (en)	2013-11-28
DE10360792A1 (de)	2005-07-28
WO2005066183A1 (de)	2005-07-21
HRP20080272T3 (en)	2008-09-30
MXPA06007171A (es)	2006-08-23
NZ548317A (en)	2010-01-29
DE502004006697D1 (de)	2008-05-08

Publication	Publication Date	Title
DK1725567T3 (da)	2008-06-16	Spirocykliske cyclohexanderivater med affinitet for ORL1-receptoren
ATE441650T1 (de)	2009-09-15	Spirocyclische cyclohexan-derivate
ATE426604T1 (de)	2009-04-15	Spirocyclische cyclohexan-derivate
ATE451364T1 (de)	2009-12-15	Als modulatoren des dopamin-d3-rezeptors geeignete azabicycloä3.1.0ühexanderivate
DE602005027307D1 (de)	2011-05-19	Arylanilinderivate als agonisten des beta2-adrenergen rezeptors
DK3524611T3 (da)	2021-04-06	Forbedrede cytotoksiske midler med nye maytansinoider
EP1761430A4 (en)	2011-09-21	ROTARY VEIL VEHICLE
PT2570128T (pt)	2016-10-07	Antagonistas do receptor muscarínico de acetilcolina
NO20041578D0 (no)	2004-04-19	Motorsykkel med justerbare kjorestillinger
FR2875753B1 (fr)	2008-08-08	Dispositif de reglage pour siege
DK1948607T3 (da)	2010-07-26	Cyclopropylaminer med histamin-H3-receptormodulatorer
DE602007008831D1 (de)	2010-10-14	Cyclohexyl-sulfonamid-derivate mit h3-rezeptoraktivität
DE602005014534D1 (de)	2009-07-02	Steuervorrichtung mit Beschleunigungsmesser
ZA200604791B (en)	2008-07-30	Hydronopol derivatives as agonists on human ORL1 receptors
DE602004014772D1 (de)	2008-08-14	Pyrrol-2,5-dithionderivate als modulatoren des liver-x-rezeptors
DK1636206T3 (da)	2008-02-11	Imidazolderivater som glutamatreceptorantagonister
DK1778243T3 (da)	2013-02-04	Substituerede azepinderivater som serotoninreceptormodulatorer
DK1928821T3 (da)	2009-03-16	Carboxamidderivater som muscarinreceptorantagonister
EP1755603A4 (en)	2009-03-11	3,3-DISUBSTITUTED TETRAHYDROPYRANYL CYCLOPENTYL AMIDE MODULATORS OF CHEMOKIN RECEPTOR ACTIVITY
NL2000336A1 (nl)	2007-06-05	Spirocyclische derivaten.
DK1605876T3 (da)	2009-12-14	Antikonceptionsindretning med integreret vulstkonstruktion
ATE424367T1 (de)	2009-03-15	Stelleinrichtung
ITMI20052320A1 (it)	2007-06-06	Dispositivo di regolazione dell'altezza di selle o manubri
SE0400785L (sv)	2005-08-23	Kompenseringsanordning
EP1847546A4 (en)	2008-05-07	imidazopyridine derivative